Key findings

There is no association between the most widely used antacid ranitidine and the development of cancer, according to a multinational meta-analysis of European, US, and Asian databases in JAMA Network Open .

Background and/or implications

Regulatory authorities suspended or withdrew approval of ranitidine, a histamine-2 receptor antagonist, owing ...